| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 59864* | 2014 |
| Edoxaban versus warfarin in patients with atrial fibrillation RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ... New England Journal of Medicine 369 (22), 2093-2104, 2013 | 6089 | 2013 |
| Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised … PA Poole-Wilson, K Swedberg, JGF Cleland, A Di Lenarda, P Hanrath, ... The Lancet 362 (9377), 7-13, 2003 | 2743 | 2003 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2566 | 2017 |
| A clinical trial of the angiotensin-converting–enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction L Køber, C Torp-Pedersen, JE Carlsen, H Bagger, P Eliasen, K Lyngborg, ... New England Journal of Medicine 333 (25), 1670-1676, 1995 | 2382 | 1995 |
| Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ... The Lancet 355 (9215), 1575-1581, 2000 | 2357 | 2000 |
| Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population T Willum Hansen, JA Staessen, C Torp-Pedersen, S Rasmussen, L Thijs, ... Circulation 113 (5), 664-670, 2006 | 2083 | 2006 |
| 2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European Society of … H Baumgartner, J De Backer, SV Babu-Narayan, W Budts, M Chessa, ... European heart journal 42 (6), 563-645, 2021 | 1874 | 2021 |
| Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study JB Olesen, GYH Lip, ML Hansen, PR Hansen, JS Tolstrup, J Lindhardsen, ... Bmj 342, 2011 | 1739 | 2011 |
| Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors:‘establishing normal and reference values’ Reference Values for Arterial Stiffness' Collaboration European heart journal 31 (19), 2338-2350, 2010 | 1651 | 2010 |
| Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity K Malmberg, L Rydén, H Wedel, K Birkeland, A Bootsma, K Dickstein, ... European heart journal 26 (7), 650-661, 2005 | 1517 | 2005 |
| Effect of dronedarone on cardiovascular events in atrial fibrillation SH Hohnloser, HJGM Crijns, M van Eickels, C Gaudin, RL Page, ... New England Journal of Medicine 360 (7), 668-678, 2009 | 1478 | 2009 |
| Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest M Wissenberg, FK Lippert, F Folke, P Weeke, CM Hansen, ... Jama 310 (13), 1377-1384, 2013 | 1461 | 2013 |
| Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and … SJ Connolly, J Pogue, J Eikelboom, G Flaker, P Commerford, ... Circulation 118 (20), 2029-2037, 2008 | 1391* | 2008 |
| Increased mortality after dronedarone therapy for severe heart failure L Køber, C Torp-Pedersen, JJV McMurray, O Gøtzsche, S Lévy, H Crijns, ... New England Journal of Medicine 358 (25), 2678-2687, 2008 | 1239 | 2008 |
| Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ... New England Journal of Medicine 363 (10), 905-917, 2010 | 1229 | 2010 |
| Defibrillator implantation in patients with nonischemic systolic heart failure L Køber, JJ Thune, JC Nielsen, J Haarbo, L Videbæk, E Korup, G Jensen, ... New England Journal of Medicine 375 (13), 1221-1230, 2016 | 1208 | 2016 |
| Dofetilide in patients with congestive heart failure and left ventricular dysfunction C Torp-Pedersen, M Møller, PE Bloch-Thomsen, L Køber, E Sandøe, ... New England Journal of Medicine 341 (12), 857-865, 1999 | 1170 | 1999 |
| Stroke and bleeding in atrial fibrillation with chronic kidney disease JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ... New England Journal of Medicine 367 (7), 625-635, 2012 | 1151 | 2012 |
| Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ... Archives of internal medicine 170 (16), 1433-1441, 2010 | 1080 | 2010 |
